FDA Grants 510(k) Clearance to Venus the Versa Pro System

The U.S. Food and Drug Administration has granted marketing clearance to Venus Concept Inc.’s  Venus Versa Pro System.

Venus Versa is customizable and upgradable and supports 10 optional applicators which utilize Venus Concept’s (MP)2, IPL and NanoFractional RF technologies. 

The new system expands on the Venus Versa platform by incorporating proprietary advances in NanoFractional RF technologies from Venus VivaMD for higher power and deeper skin penetration, the Company reports.

"The Venus Versa Pro System once again demonstrates our commitment to continue to build upon our robust R&D pipeline," says Hemanth Varghese, President & Chief Innovation and Business Officer of Venus Concept in a news release. "The advancements we are introducing in the Venus Versa Pro System, will provide superior, comprehensive technologies to support our existing and future customers, and address the growing demand for multi-modal solutions in aesthetics. Venus Versa has been one of the company’s best-selling products over the last five years with thousands of installations worldwide. We are confident that its new generation Venus Versa Pro System, can surpass the success of Venus Versa, offering our existing customer base an attractive upgrade option, as well as offering new customers a new standard of care to address nearly all their patient’s aesthetic concerns with one platform. We look forward to formally announcing our commercial launch in the coming weeks."